Slit2 Exerts Anti-Inflammatory Actions in Human Placenta and is Decreased with Maternal Obesity

American Journal of Reproductive Immunology

Volumn 73, Issue 1, 2015, Pages 66-78

  Lim, Ratana ^a,b   Lappas, Martha ^a,b  

^a MERCY HOSPITAL FOR WOMEN   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cytokines; Inflammation; Obesity; Placenta; Slit2

Indexed keywords

AUTACOID; CYTOKINE; GELATINASE B; LIPOPOLYSACCHARIDE; NERVE PROTEIN; SIGNAL PEPTIDE; SLIT HOMOLOG 2 PROTEIN; SMALL INTERFERING RNA;

ADULT; CELL CULTURE; CYTOLOGY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATION; TROPHOBLAST;

ADULT; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 9; NERVE TISSUE PROTEINS; OBESITY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; RNA, SMALL INTERFERING; TROPHOBLASTS;

EID: 84928322940     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12334     Document Type: Article

References (52)

1. Colagiuri S, Lee CMY, Colagiuri R, Magliano D, Shaw JE, Zimmet PZ, Caterson ID: The cost of overweight and obesity in Australia. Med J Australia 2010; 192:260-264.
2. Chu SY, Bachman DJ, Callaghan WM, Whitlock EP, Dietz PM, Berg CJ, O'Keeffe-Rosetti M, Bruce FC, Hornbrook MC: Association between obesity during pregnancy and increased use of health care. New Engl J Med 2008; 358:1444-1453.
3. Kelly T, Yang W, Chen CS, Reynolds K, He J: Global burden of obesity in 2005 and projections to 2030. Int J Obes 2008; 32:1431-1437.
4. Hossain P, Kawar B, El Nahas M: Obesity and diabetes in the developing world - a growing challenge. N Engl J Med 2007; 356:213-215.
5. Wang H, Du S, Zhai F, Popkin BM: Trends in the distribution of body mass index among Chinese adults, aged 20-45 years (1989-2000). Int J Obes 2007; 31:272-278.
6. Heslehurst N, Rankin J, Wilkinson JR, Summerbell CD: A nationally representative study of maternal obesity in England, UK: trends in incidence and demographic inequalities in 619 323 births, 1989-2007. Int J Obes 2010; 34:420-428.
7. Callaway LK, Prins JB, Chang AM, McIntyre HD: The prevalence and impact of overweight and obesity in an Australian obstetric population. Med J Australia 2006; 184:56-59.
8. Ehrenberg HM, Mercer BM, Catalano PM: The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol 2004; 191:964-968.
9. Surkan PJ, Hsieh CC, Johansson AL, Dickman PW, Cnattingius S: Reasons for increasing trends in large for gestational age births. Obstet Gynecol 2004; 104:720-726.
10. Hull HR, Dinger MK, Knehans AW, Thompson DM, Fields DA: Impact of maternal body mass index on neonate birthweight and body composition. Am J Obstet Gynecol 2008; 198:416.e1-6.
11. Boney CM, Verma A, Tucker R, Vohr BR: Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115:e290-e296.
12. Drake AJ, Reynolds RM: Impact of maternal obesity on offspring obesity and cardiometabolic disease risk. Reproduction 2010; 140:387-398.
13. Jarvie E, Hauguel-de-Mouzon S, Nelson SM, Sattar N, Catalano PM, Freeman DJ: Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci 2010; 119:123-129.
14. Basu S, Haghiac M, Surace P, Challier JC, Guerre-Millo M, Singh K, Waters T, Minium J, Presley L, Catalano PM, Hauguel-de Mouzon S: Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity 2011; 19:476-482.
15. Challier JC, Basu S, Bintein T, Minium J, Hotmire K, Catalano PM, Mouzon SHD: Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008; 29:274-281.
16. Madan JC, Davis JM, Craig WY, Collins M, Allan W, Quinn R, Dammann O: Maternal obesity and markers of inflammation in pregnancy. Cytokine 2009; 47:61-64.
17. Roberts KA, Riley SC, Reynolds RM, Barr S, Evans M, Statham A, Hor K, Jabbour HN, Norman JE, Denison FC: Placental structure and inflammation in pregnancies associated with obesity. Placenta 2011; 32:247-254.
18. Aye IL, Jansson T, Powell TL: Interleukin-1beta inhibits insulin signaling and prevents insulin-stimulated system A amino acid transport in primary human trophoblasts. Mol Cell Endocrinol 2013; 381:46-55.
19. Saben J, Zhong Y, Gomez-Acevedo H, Thakali KM, Borengasser SJ, Andres A, Shankar K: Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: role in maternal obesity. Am J Physiol Endocrinol Metab 2013; 305:E1-14.
20. Aye IL, Lager S, Ramirez VI, Gaccioli F, Dudley DJ, Jansson T, Powell TL: Increasing maternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways. Biol Reprod 2014; 90:129.
21. Lim R, Barker G, Lappas M: SLIT3 is increased in supracervical human foetal membranes and in labouring myometrium and regulates pro-inflammatory mediators. Am J Reprod Immunol 2014; 71:297-311.
22. Jones HN, Jansson T, Powell TL: IL-6 stimulates system A amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2. Am J Physiol-Cell Ph 2009; 297:C1228-C1235.
23. Liao WX, Laurent LC, Agent S, Hodges J, Chen DB: Human placental expression of SLIT/ROBO signaling cues: effects of preeclampsia and hypoxia. Biol Reprod 2012; 86:111.
24. Tanno T, Fujiwara A, Sakaguchi K, Tanaka K, Takenaka S, Tsuyama S: Slit3 regulates cell motility through Rac/Cdc42 activation in lipopolysaccharide-stimulated macrophages. FEBS Lett 2007; 581:1022-1026.
25. Geutskens SB, Hordijk PL, van Hennik PB: The chemorepellent Slit3 promotes monocyte migration. J Immunol 2010; 185:7691-7698.
26. Zhao H, Anand AR, Ganju RK: Slit2-Robo4 pathway modulates lipopolysaccharide-induced endothelial inflammation and its expression is dysregulated during endotoxemia. J Immunol 2014; 192:385-393.
27. Denk AE, Kaufmann S, Stark K, Schedel J, Lowin T, Schubert T, Bosserhoff AK: Slit3 inhibits Robo3-induced invasion of synovial fibroblasts in rheumatoid arthritis. Arthritis Res Ther 2010; 12:R45.
28. Liao WX, Wing DA, Geng JG, Chen DB: Perspectives of SLIT/ROBO signaling in placental angiogenesis. Histol Histopathol 2010; 25:1181-1190.
29. Lager S, Gaccioli F, Ramirez VI, Jones HN, Jansson T, Powell TL: Oleic acid stimulates system A amino acid transport in primary human trophoblast cells mediated by toll-like receptor 4. J Lipid Res 2013; 54:725-733.
30. Lim R, Barker G, Lappas M: TREM-1 expression is increased in human placentas from severe early-onset preeclamptic pregnancies where it may be involved in syncytialization. Reprod Sci (Thousand Oaks, Calif) 2013; 21:562-572.
31. Lappas M: Forkhead box O1 (FOXO1) in pregnant human myometrial cells: a role as a pro-inflammatory mediator in human parturition. J Reprod Immunol 2013; 99:24-32.
32. Kanellis J, Garcia GE, Li P, Parra G, Wilson CB, Rao Y, Han S, Smith CW, Johnson RJ, Wu JY, Feng L: Modulation of inflammation by slit protein in vivo in experimental crescentic glomerulonephritis. Am J Pathol 2004; 165:341-352.
33. Lappas M, Permezel M, Rice GE: Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab 2004; 89:5627-5633.
34. Wu JY, Feng L, Park HT, Havlioglu N, Wen L, Tang H, Bacon KB, Jiang Z, Zhang X, Rao Y: The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature 2001; 410:948-952.
35. Tole S, Mukovozov IM, Huang YW, Magalhaes MA, Yan M, Crow MR, Liu GY, Sun CX, Durocher Y, Glogauer M, Robinson LA: The axonal repellent, Slit2, inhibits directional migration of circulating neutrophils. J Leukoc Biol 2009; 86:1403-1415.
36. London NR, Zhu W, Bozza FA, Smith MC, Greif DM, Sorensen LK, Chen L, Kaminoh Y, Chan AC, Passi SF, Day CW, Barnard DL, Zimmerman GA, Krasnow MA, Li DY: Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci Transl Med 2010; 2:23ra19.
37. Lager S, Jansson N, Olsson AL, Wennergren M, Jansson T, Powell TL: Effect of IL-6 and TNF-alpha on fatty acid uptake in cultured human primary trophoblast cells. Placenta 2011; 32:121-127.
38. Vu TH, Werb Z: Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 2000; 14:2123-2133.
39. Fata JE, Ho ATV, Leco KJ, Moorehead RA, Khokha R: Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors. Cell Mol Life Sci 2000; 57:77-95.
40. Sternlicht MD, Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17:463-516.
41. Manicone AM, McGuire JK: Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 2008; 19:34-41.
42. Parks WC, Wilson CL, Lopez-Boado YS: Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004; 4:617-629.
43. Schonbeck U, Mach F, Libby P: Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 1998; 161:3340-3346.
44. Van den Steen PE, Wuyts A, Husson SJ, Proost P, Van Damme J, Opdenakker G: Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur J Biochem 2003; 270:3739-3749.
45. Pustovrh MC, Jawerbaum A, Capobianco E, White V, Lopez-Costa JJ, Gonzalez E: Increased matrix metalloproteinases 2 and 9 in placenta of diabetic rats at midgestation. Placenta 2005; 26:339-348.
46. Capobianco E, White V, Sosa M, Di MarcoI, Basualdo MN, Faingold MC, Jawerbaum A: Regulation of matrix metalloproteinases 2 and 9 activities by peroxynitrites in term placentas from type 2 diabetic patients. Reprod Sci (Thousand Oaks, Calif) 2012; 19:814-822.
47. Lappas M: Nuclear factor-B mediates placental growth factor induced pro-labour mediators in human placenta. Mol Hum Reprod 2012; 18:354-361.
48. Hohenester E: Structural insight into Slit-Robo signalling. Biochem Soc Trans 2008; 36:251-256.
49. Brose K, Bland KS, Wang KH, Arnott D, Henzel W, Goodman CS, Tessier-Lavigne M, Kidd T: Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell 1999; 96:795-806.
50. Liang Y, Annan RS, Carr SA, Popp S, Mevissen M, Margolis RK, Margolis RU: Mammalian homologues of the Drosophila slit protein are ligands of the heparan sulfate proteoglycan glypican-1 in brain. J Biol Chem 1999; 274:17885-17892.
51. Ronca F, Andersen JS, Paech V, Margolis RU: Characterization of Slit protein interactions with glypican-1. J Biol Chem 2001; 276:29141-29147.
52. Chang PH, Hwang-Verslues WW, Chang YC, Chen CC, Hsiao M, Jeng YM, Chang KJ, Lee EY, Shew JY, Lee WH: Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/beta-catenin pathway. Cancer Res 2012; 72:4652-4661.